Fedratinib
Category: CancerFedratinib Overview
Fedratinib (trade name Inrebic, formerly known as TG101348; SAR302503), also known as fedratinib hydrochloride, is an orally available semi-selective inhibitor of Janus kinase 2 (JAK-2) developed for the treatment of patients with myeloproliferative diseases including myelofibrosis.[1][2] Fedratinib acts as a competitive inhibitor of protein kinase JAK-2 with IC50=6 nM; related kinases FLT3 and RET are also sensitive, with IC50=25 nM and IC50=17 nM, respectivel...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fedratinib
Recent Fedratinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Fedratinib
- Capsule: 100mg
Other drugs which contain Fedratinib or a similar ingredient: (1 result)
- INREBIC Fedratinib Hydrochloride